These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 24066893)

  • 1. Novel strategies for development of next-generation glycoconjugate vaccines.
    Avci FY
    Curr Top Med Chem; 2013; 13(20):2535-40. PubMed ID: 24066893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A semisynthetic
    Schumann B; Hahm HS; Parameswarappa SG; Reppe K; Wahlbrink A; Govindan S; Kaplonek P; Pirofski LA; Witzenrath M; Anish C; Pereira CL; Seeberger PH
    Sci Transl Med; 2017 Mar; 9(380):. PubMed ID: 28275152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T Cell-Mediated Humoral Immune Responses to Type 3 Capsular Polysaccharide of
    Middleton DR; Sun L; Paschall AV; Avci FY
    J Immunol; 2017 Jul; 199(2):598-603. PubMed ID: 28566369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate-Based Vaccines: An Overview.
    Hütter J; Lepenies B
    Methods Mol Biol; 2015; 1331():1-10. PubMed ID: 26169731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent mechanistic insights on glycoconjugate vaccines and future perspectives.
    Berti F; Adamo R
    ACS Chem Biol; 2013 Aug; 8(8):1653-63. PubMed ID: 23841819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential targets for next generation antimicrobial glycoconjugate vaccines.
    Micoli F; Costantino P; Adamo R
    FEMS Microbiol Rev; 2018 May; 42(3):388-423. PubMed ID: 29547971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines.
    Sun X; Stefanetti G; Berti F; Kasper DL
    Proc Natl Acad Sci U S A; 2019 Jan; 116(1):193-198. PubMed ID: 30510007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CONTEMPORARY CONCEPTION OF IMMUNE RESPONSE ACTIVATION MECHA- NISM BY CONJUGATED POLYSACCHARIDE VACCINES].
    Kolesnikov AV; Kozyr AV; Schemyakin IG; Dyatlov IA
    Zh Mikrobiol Epidemiol Immunobiol; 2015; (3):97-106. PubMed ID: 26259279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of O-Acetylation in the Immunogenicity of Bacterial Polysaccharide Vaccines.
    Berti F; De Ricco R; Rappuoli R
    Molecules; 2018 Jun; 23(6):. PubMed ID: 29865239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic carbohydrate-based vaccines: challenges and opportunities.
    Mettu R; Chen CY; Wu CY
    J Biomed Sci; 2020 Jan; 27(1):9. PubMed ID: 31900143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoconjugate vaccines.
    Pace D
    Expert Opin Biol Ther; 2013 Jan; 13(1):11-33. PubMed ID: 22992106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoconjugate vaccines: an update.
    Vella M; Pace D
    Expert Opin Biol Ther; 2015 Apr; 15(4):529-46. PubMed ID: 25496172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Overview of Structural Features of Antibacterial Glycoconjugate Vaccines That Influence Their Immunogenicity.
    Khatun F; Stephenson RJ; Toth I
    Chemistry; 2017 Mar; 23(18):4233-4254. PubMed ID: 28097690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design.
    Avci FY; Li X; Tsuji M; Kasper DL
    Nat Med; 2011 Nov; 17(12):1602-9. PubMed ID: 22101769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generalized Modules for Membrane Antigens as Carrier for Polysaccharides: Impact of Sugar Length, Density, and Attachment Site on the Immune Response Elicited in Animal Models.
    Micoli F; Alfini R; Di Benedetto R; Necchi F; Schiavo F; Mancini F; Carducci M; Oldrini D; Pitirollo O; Gasperini G; Balocchi C; Bechi N; Brunelli B; Piccioli D; Adamo R
    Front Immunol; 2021; 12():719315. PubMed ID: 34594333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carrier priming effect of CRM197 is related to an enhanced B and T cell activation in meningococcal serogroup A conjugate vaccination. Immunological comparison between CRM197 and diphtheria toxoid.
    Pecetta S; Tontini M; Faenzi E; Cioncada R; Proietti D; Seubert A; Nuti S; Berti F; Romano MR
    Vaccine; 2016 Apr; 34(20):2334-41. PubMed ID: 27015733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the Effect of Conjugation Site and Chemistry on the Immunogenicity of an anti-Group B Streptococcus Glycoconjugate Vaccine Based on GBS67 Pilus Protein and Type V Polysaccharide.
    Nilo A; Passalacqua I; Fabbrini M; Allan M; Usera A; Carboni F; Brogioni B; Pezzicoli A; Cobb J; Romano MR; Margarit I; Hu QY; Berti F; Adamo R
    Bioconjug Chem; 2015 Aug; 26(8):1839-49. PubMed ID: 26230938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Streptococcus pneumoniae Type 2 Oligosaccharide Glycoconjugate Elicits Opsonic Antibodies and Is Protective in an Animal Model of Invasive Pneumococcal Disease.
    Emmadi M; Khan N; Lykke L; Reppe K; G Parameswarappa S; Lisboa MP; Wienhold SM; Witzenrath M; Pereira CL; Seeberger PH
    J Am Chem Soc; 2017 Oct; 139(41):14783-14791. PubMed ID: 28945368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against Streptococcus suis Serotype 2 Infection Using a Capsular Polysaccharide Glycoconjugate Vaccine.
    Goyette-Desjardins G; Calzas C; Shiao TC; Neubauer A; Kempker J; Roy R; Gottschalk M; Segura M
    Infect Immun; 2016 Jul; 84(7):2059-2075. PubMed ID: 27113360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating the candidacy of a capsular polysaccharide-based glycoconjugate as a vaccine to combat Haemophilus influenzae type a disease: A solution for an unmet public health need.
    Cox AD; Williams D; Cairns C; St Michael F; Fleming P; Vinogradov E; Arbour M; Masson L; Zou W
    Vaccine; 2017 Oct; 35(45):6129-6136. PubMed ID: 28951087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.